ArticleJournal of ovarian research2026
SS-31 improves the quality of maternally aged oocytes by ameliorating mitochondrial function and metabolism.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Reproductive aging is closely associated with poor oocyte quality in vitro maturation, but effective approaches to ameliorate it have still not been fully determined. Here, we found that SS-31 supplementation efficaciously improved oocyte maturation and early embryonic development from aged mice. Specifically, SS-31 remarkably restored the normal spindle/chromosome structure, fertilization ability, mitochondrial distribution, ΔΨm and mitophagy in aged oocytes. In contrast, SS-31 reduced oocyte aneuploidy, ROS accumulation and DNA damage. Mechanistically, single-cell transcriptome analysis reveals that SS-31 increased the maternal mRNA degradation, and the levels of genes associated with mitochondrial function and mitophagy in aged oocytes, such as Pink1, Rps27a, Tomm7 and Map1lc3b. In addition, SS-31 suppressed chromatin organization, histone modification and chromatin remodeling pathways. Moreover, we applied the single-cell untargeted metabolomics to identify that SS-31 increased the levels of spermidine and GSH, which were critical metabolites to protect oocytes against aging. Our data reveal that the beneficial effect of SS-31 on oocyte quality from advanced age is mainly mediated by restoration of mitochondrial function, mitophagy and anti-aging metabolites. It provides a potential strategy for improving oocyte quality to extend the reproductive lifespan of female animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.